pocketful logo
Sanofi India Ltd logo

Sanofi India Ltd

NSE: SANOFI BSE: 500674

₹3209.70

(0.59%)

Wed, 01 Apr 2026, 01:27 pm

mtf coin illustrationMTF 5x

Sanofi India Share Price Live Chart

1 Day

0 (0%)

No Result Found

Summary

  • Market Cap

    7385.72

  • Net Profit

    413.30

  • P/B

    16.36

  • Sector P/E

    31.44

  • P/E

    34.06

  • EV/EBITDA

    24.25

  • Debt/Equity (Industry)

    0.09

  • Interest Cover (Industry)

    40.26

  • ROCE (Industry)

    22.97

  • RONW (Industry)

    18.34

  • ROE

    47.13

  • ROCE

    47.95

  • Debt/Equity

    0.02

  • EPS (TTM)

    164.93

  • Dividend Yield

    3.64

  • Book Value

    373.70

  • Interest Cover

    313.73

Analysis

all

thumbs up icon

Pros

  • Dividends per share have increased over the past 10 years.
  • Dividends paid are covered by earnings (1.7x coverage).
  • Sanofi India's pays a higher dividend yield than the bottom 25% of dividend payers in India (0.76%).
  • Sanofi India is able to meet its short term (1 year) commitments with its holdings of cash and other short term assets.
  • Sanofi India is profitable, therefore cash runway is not a concern.
thumbs up icon

Cons

  • Dividends per share have been volatile in the past 10 years (annual drop of over 20%).
  • Sanofi India's dividend is below the markets top 25% of dividend payers in India (3.08%).
  • High level of physical assets or inventory.
  • Sanofi India is not covered by any analysts.
  • Sanofi India's 1-year earnings growth is less than its 5-year average (4% vs 14%)

Read More

Financials

Read More

Ratios

Read More

Shareholding

ShareholdersDEC 2025SEPT 2025JUN 2025MAR 2025DEC 2024
Promoters60.4060.4060.4060.4060.40
FII5.555.575.615.575.63
DII21.3122.2923.0623.0222.93
Public12.7411.7410.9411.0111.04
Government00000

Read More

Technical Analysis

RSI

28.14

MACD

-189.04

50 DMA

3826.35

200 DMA

4702.39

Support and Resistance

TypeR3R2R1PPS1S2S3
Classic4903.234163.233686.473423.232946.472683.231943.23
Fibonacci4163.233880.553705.913423.233140.552965.912683.23
Camarilla3413.203345.373277.533423.233141.873074.033006.20

Pivots Level: Classic

R3

+1480

4903.23

R2

+740

4163.23

R1

+263.23

3686.47

3423.23
3423.23
Pivot Point
LTP: 3262.40

S1

-476.77

2946.47

S2

-740

2683.23

S3

-1480

1943.23

Moving Average

SMAEMA

Period

Value

  • 10-EMA

    3328.52

  • 20-EMA

    3477.35

  • 30-EMA

    3590.64

  • 50-EMA

    3752.74

  • 100-EMA

    4060.65

  • 200-EMA

    4523.34

Read More

Corporate Actions

Announcement DatePurposeActionEx Date
25 Mar 2026agm
25 Feb 2026dividend₹48.00 Dividend /Share22 Apr 2026
25 Feb 2026board-meetingsAccounts, Quarterly Results, Final Dividend
29 Oct 2025board-meetingsQuarterly Results, Nine Months Results, Interim Dividend
29 Oct 2025dividend₹75.00 Dividend /Share07 Nov 2025
07 Oct 2025dividendInterim Dividend - Rs. - 7507 Nov 2025
25 Mar 2025dividendFinal Dividend - Rs. - 11725 Apr 2025
18 Mar 2025agm
27 Feb 2025dividend₹117.00 Dividend /Share25 Apr 2025
03 Apr 2024dividendFinal Dividend - Rs. - 11703 May 2024

Read More

Peer Comparison

Sanofi India Ltd logo

Sanofi India Ltd

Divis Laboratories Ltd logo

Divis Laboratories Ltd

Dr Reddys Laboratories Ltd logo

Dr Reddys Laboratories Ltd

Lupin Ltd logo

Lupin Ltd

Sun Pharmaceutical Industries Ltd logo

Sun Pharmaceutical Industries Ltd

Torrent Pharmaceuticals Ltd logo

Torrent Pharmaceuticals Ltd

Read More

Sanofi India Ltd About

Sanofi India is primarily engaged in the business of manufacturing and trading of drugs and pharmaceuticals. The Company has its own manufacturing facility at Goa. The Company also has various independent contract / third party manufacturers based across the country. The Company sells its products

Industry

Pharmaceuticals - Multinational

Founded

1956

Headquarters

CEO

Aditya Narayan

Employees

Contact

Website icon

Website

http://www.sanofiindialtd.com

Email icon

Email

igrc.sil@sanofi.com

Phone icon

Phone

91-22-28032000

Location icon

Location

Sanofi Hse 117-B Saki Vihar Rd, L&T Business Park Powai, Mumbai, Maharashtra, 400072

Read More

Sanofi India Ltd Company History

YearHistory
2019
  • Sanofi India partnered to reduce diabetes burden on state's health exchequer.
2020
  • Sanofi Pasteur launched VaxLine in India.
  • Sanofi India launched Allergy Free.
  • Sanofi Pasteur launched Tetraxim DTaP booster vaccine for preschoolers in India.
2021
  • Sanofi India announced sale and transfer of Nutraceuticals business to Universal Nutriscience.
  • Sanofi and GSK received approval for Phase 3 trial of COVID-19 vaccine candidate in India.
2023
  • Sanofi received marketing approval for diabetes drug Soliqua in India.
2024
  • Sanofi announced expansion of its Global Capability Centre in Hyderabad.
  • Sanofi received marketing authorization for Beyfortus in India against RSV.
  • Sanofi and Cipla announced exclusive distribution partnership for CNS portfolio in India.

Read More

Deals

Client NameOrder SideQTYAvg PriceDate
No Result Found

Read More

Sanofi India Ltd News

Sanofi India publishes newspaper notice for 70th AGM

Sanofi India Limited published newspaper notice regarding 70th Annual General Meeting scheduled on April 29, 2026, record date for final dividend of Rs. 48 per share, and special window for share transfer requests.

31 Mar 2026

companies

Sanofi India Faces ₹12.37 Cr Tax Liability Order

Sanofi India receives income tax assessment order for FY 2022-23 with tax liability of ₹12.37 crores including interest. Company plans to appeal against transfer pricing adjustments and disallowed payments.

28 Mar 2026

companies

Sanofi India Board approves AGM, dividend & new director

Sanofi India Limited Board approves 70th AGM for April 29, 2026, final dividend of Rs. 48 per share with record date April 22, and appoints Siraj Azmat Chaudhry as Independent Director for 5-year term.

26 Mar 2026

companies

Sanofi India Board approves AGM, dividend & new director

Sanofi India Limited Board approves 70th AGM for April 29, 2026, final dividend of Rs. 48 per share with record date April 22, and appoints Siraj Azmat Chaudhry as Independent Director for 5-year term.

25 Mar 2026

companies

Sanofi India Board approves AGM, dividend & new director

Sanofi India Limited Board approves 70th AGM for April 29, 2026, final dividend of Rs. 48 per share with record date April 22, and appoints Siraj Azmat Chaudhry as Independent Director for 5-year term.

25 Mar 2026

companies

Read More

Open Your Free Demat Account Now!

Step into a world of zero fees and limitless opportunities!

pocketful logo

2022-25 Pocketful. All rights reserved, Built with in India

Version -5.76

app image 1app image 2

Stocks:

AllABCDEFGHIJKLMNOPQRSTUVWXYZ

Explore

Calculatorsfooter arrow down icon
Popular Calculatorsfooter arrow down icon
Group Stocksfooter arrow down icon

Others:

NSEBSECDSLNSDLSEBIMCXMSEINCDEXNSE IFSCINDIA INXAccount Closure FormDP Investor CharterBroker Investor Charter

Pocketful Fintech Capital Private Limited (CIN U65999DL2021PTC390548) | The SEBI Registration No. allotted to us is INZ000313732. NSE Member Code: 90326 | BSE Member Code: 6808 | MCX Member Code: 57120 DP | CDSL: 12099800